연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
1405. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
Kim JY1, Han W, Moon HG, Park IA, Ahn SK, Kim J, Lee JW, Kim T, Kim MK, Noh DY.
Clin Breast Cancer. 2013 Oct;13(5):385-91. doi: 10.1016/j.clbc.2013.04.005. Epub 2013 Jul 17.
Link
1404. Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis.
Jeong JC, Kim JE, Ryu JW, Joo KW, Kim HK.
Thromb Res. 2013 Nov;132(5):604-9. doi: 10.1016/j.thromres.2013.09.002. Epub 2013 Sep 6.
Link
1403. Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.
Hong SK, Kim JE, Han KS, Kim HK.
Thromb Res. 2013 Sep;132(3):392-7. doi: 10.1016/j.thromres.2013.07.025. Epub 2013 Aug 3.
Link
1402. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q, Kim JE, Hyun J, Han KS, Kim HK.
Thromb Res. 2013 Jul;132(1):e70-5. doi: 10.1016/j.thromres.2013.05.015. Epub 2013 Jun 13.
Link
1401. Serum des-R prothrombin activation peptide fragment 2: a novel prognostic marker for disseminated intravascular coagulation.
Chung S, Kim JE, Kim HK, Yeon EH, Shin YS, Kim CW.
Thromb Res. 2013 Jun;131(6):547-53. doi: 10.1016/j.thromres.2013.04.015. Epub 2013 May 7.
Link
1400. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
Youngwon N, Kim JE, Lim HS, Han KS, Kim HK.
Biomed Res Int. 2013;2013:856754. doi: 10.1155/2013/856754. Epub 2013 Feb 21.
Link
1399. Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults.
Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S.
Am J Clin Pathol. 2013 Mar;139(3):370-9. doi: 10.1309/AJCPC5C4AGFRDKMX.
Link
1398. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S.
Blood Coagul Fibrinolysis. 2013 Mar;24(2):150-6. doi: 10.1097/MBC.0b013e32835aef6b.
Link
1397. Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line.
Lee YY1, Kim HP, Kang MJ, Cho BK, Han SW, Kim TY, Yi EC.
Exp Mol Med. 2013 Nov 22;45:e64. doi: 10.1038/emm.2013.115.
Link
1396. Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.
Kang MJ1, Kim HP, Lee KS, Yoo YD, Kwon YT, Kim KM, Kim TY, Yi EC.
Proteomics. 2013 May;13(10-11):1714-25. doi: 10.1002/pmic.201200511. Epub 2013 Apr 23.
Link